CD4 and cancer: We showed that the identified pathway activity profiles can be of help in elucidating the mechanism leading to cancer-induced immunotolerance and to investigate the type and the functional state of CD4+ T cells in blood, lymph nodes, and TIL samples from cancer patients [19].